Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

Toshiaki Takahashi, Takeharu Yamanaka, Takashi Seto, +13

The Lancet Oncology

Radiation MedicineRadiation TherapyMedicineClinical Radiation OncologyOncology +4

Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402

Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, +13

Journal of Clinical Oncology

Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.

Osamu Ishimoto, Chikashi Kawahara, Kentaro Enjo, +3

PubMed

EngineeringGeneticsHuman PolymorphismPathologyCell Death +17

Granulocyte-Macrophage Colony–Stimulating Factor and Lung Immunity in Pulmonary Alveolar Proteinosis

Ryushi Tazawa, Emi Hamano, Toru Arai, +14

American Journal of Respiratory and Critical Care Medicine

Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Results of a Japanese randomized phase III trial.

Takashi Seto, Toshiaki Takahashi, Takeharu Yamanaka, +13

Journal of Clinical Oncology

Detrimental EffectHigh-grade GliomasMetronomic ChemotherapyGliomaOverall Survival +19

High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of Cancer

Osamu Ishimoto, Yasuo Saijo, Ko Narumi, +6

Oncology

ImmunologyPathologyPleural EffusionAngiogenic CytokinesVascular Permeability +18

A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405

Akira Inoue, Osamu Ishimoto, Shinichi Fukumoto, +12

Annals of Oncology

Elderly PatientsMedicinePharmacologyPhase Ii StudyAnti-cancer Agent +5

Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study

Ryo Ko, Takehito Shukuya, Yusuke Okuma, +18

The Oncologist

A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer

Akira Inoue, Kazuhiro Usui, Osamu Ishimoto, +7

Lung Cancer

OncologyElderly PatientsPharmacologyPhase Ii StudyWeekly Paclitaxel +4

Mutation and Expression of the p51 Gene in Human Lung Cancer

Masachika Tani, Kimihiro Shimizu, Chikashi Kawahara, +4

Neoplasia